The five-year grant will support optimizing the use of polymyxin B to treat Gram-negative bacterial infections and identify protein biomarkers of drug-associated toxicity.
The researchers will use the expressed proteins to refine and optimize multiple-reaction monitoring assays that they will then apply to actual biological samples.
The partners will combine the sciFlexarrayer with Anteo's reagents to improve the functionality and shelf-life of activated glass and polymer slides and other arrays.
Stanford researchers used Fluidigm's CyTOF instrument to explore links between the diversity of natural killer (NK) cell populations and HIV susceptibility.
Having gained traction for its technology in the RUO and LDT spaces, the company is now looking to develop its reagents for use in regulatory-cleared IVDs.
The NIH has issued a preliminary guidance for newborn dried blood spot research.
Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.
In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.
In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.